Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Cells of the Innate Immune Response

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

National Acceptance and Determinants of Immersive Extended Reality in Health Care in China: Cross-Sectional Study.

Journal of medical Internet research·2026

Same author

3D-printed metamaterial femoral prostheses via scalar field fusion and directional porous structure regulation.

BMC biotechnology·2026

Same author

Natural Killer T Cell Function in Lymphoma Patients.

Biomolecules·2026

Same author

Depressive and insomnia symptoms and incident dementia risk: A 12-year study in U.S. older adults.

Journal of affective disorders·2026

Same author

Device-Induced Blood Damage in Pump-Assisted Circulation: A Comparative Study of HeartMate III and BrioVAD Pumps.

Artificial organs·2026

Same author

Design and Manufacturing Process of 3D-Printed Metamaterial Calcaneal Plates via Scalar Field-Driven Porous Structure Fusion.

ACS biomaterials science & engineering·2026

Same journal

Development and Application of Cancer Stem Cell-Targeted Vaccine in Cancer Immunotherapy.

Journal of vaccines & vaccination·2018

Same journal

MEFA (multiepitope fusion antigen)-Novel Technology for Structural Vaccinology, Proof from Computational and Empirical Immunogenicity Characterization of an Enterotoxigenic <i>Escherichia coli</i> (ETEC) Adhesin MEFA.

Journal of vaccines & vaccination·2017

Same journal

Pre-resectional Radiofrequency Ablation as a Neoadjuvant <i>in situ</i> Tumor Vaccine.

Journal of vaccines & vaccination·2017

Same journal

Elimination of Cancer Health Disparities through the Acceleration of HPV Vaccines and Vaccinations: A Simplified Version of the President's Cancer Panel Report on HPV Vaccinations.

Journal of vaccines & vaccination·2017

Same journal

Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation.

Journal of vaccines & vaccination·2017

Same journal

One-step Quantitative RT-PCR Assays for Detecting, Genotyping and Differentiating Wild-Type Group a Rotaviruses and Vaccine (Rotarix<sup>®</sup> and RotaTeq<sup>®</sup>) Strains in Stool Samples.

Journal of vaccines & vaccination·2017

See all related articles

Search research articles

Related Experiment Video

Updated: May 7, 2026

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

Natural killer T cell based Immunotherapy.

Priyanka B Subrahmanyam¹, Wenji Sun, James E East

¹Department of Microbiology and Immunology, University of Maryland School of Medicine, the Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland 21201.

Journal of Vaccines & Vaccination

|October 4, 2013

Summary

This summary is machine-generated.

Natural killer T (NKT) cells bridge innate and adaptive immunity. This review explores advances in NKT cell-based vaccination strategies for enhancing immune responses against infections and cancer.

Keywords:

CD1d NKT cells vaccines

More Related Videos

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

Natural Killer (NK) and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Natural Killer (NK) and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

Related Experiment Videos

Last Updated: May 7, 2026

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

Natural Killer (NK) and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Natural Killer (NK) and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

Area of Science:

Immunology
Vaccinology

Background:

Natural killer T (NKT) cells are crucial immune regulators bridging innate and adaptive immunity.
Activated NKT cells rapidly produce cytokines and exhibit cytotoxicity.
NKT cell agonists are explored as vaccine adjuvants to boost immune responses.

Purpose of the Study:

To review recent advancements in NKT cell-based vaccination strategies.
To highlight the therapeutic potential of modulating NKT cell effector functions.

Main Methods:

This is a review article, synthesizing existing research on NKT cells and vaccination.
Focuses on studies investigating NKT cell activation via CD1d-lipid antigen complexes.
Examines the application of NKT cell agonists in various immunotherapeutic contexts.

Main Results:

NKT cells play significant roles in autoimmune diseases, infections, cancer, transplant immunology, and dermatology.
NKT cell agonists effectively enhance antigen-specific T and B cell responses.
Recent strategies aim to harness NKT cell functions for improved vaccine efficacy.

Conclusions:

Understanding and guiding NKT cell effector functions are key to developing novel immunotherapies.
NKT cell-based vaccination strategies hold promise for treating infections, cancer, and autoimmune disorders.
Further research is needed to optimize NKT cell modulation for therapeutic benefit.